Kansas City, Kan- Lynch syndrome is a hereditary cancer syndrome affecting 1 in 279 people, with a 40-50% risk of colon cancer and 30-50% risk of uterine cancer.

Lori Chavez shares her family's history of colon and prostate cancer, leading to her own colon cancer diagnosis in 2018.

Dr. Ajay Bansal and genetic counselor Shobana Kubendran emphasize the importance of genetic testing and counseling for early detection and prevention. They highlight the need for universal genetic testing and the role of genetic counselors in providing personalized risk assessments and support.

Lori Chavez, Lynch Syndrome Survivor

• Lori Chavez shares her family history of cancer, including her father and uncle's diagnoses, and her own experience with colon cancer.
• She discusses her diagnosis in 2018, her surgery, and her positive outlook despite the challenges.
• Lori explains how her sister's diagnosis led to their family's genetic testing, confirming their Lynch syndrome.

Dr. Ajay Bansal, Gastroenterologist, The University of Kansas Health System  

• Dr. Bansal explains the clinical trial involving a vaccine for Lynch syndrome, aimed at training the immune system to detect and destroy pre-cancerous cells.
• He discusses the significance of trial participants in advancing cancer prevention research.

Shobana Kubendran, Genetic Counselor, The University of Kansas Health System  

• Shobana addresses common questions about the cost of genetic testing and the importance of insurance coverage.
• She explains the role of genetic counselors in interpreting genetic test results and providing clinically validated information.
• Shobana discusses the importance of understanding family history and personal risk factors in making informed decisions about genetic testing.

Wednesday, March 11th at 8 a.m. is the next Morning Medical Update -

5 Year Anniversary of COVID It’s been five years since COVID changed our lives. Our team of trusted doctors reflect on the virus and how it has changed the way we practice medicine.